[{"address1": "2051 Ringwood Avenue", "city": "San Jose", "state": "CA", "zip": "95131", "country": "United States", "phone": "408 457 3700", "website": "https://www.ranitherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.", "fullTimeEmployees": 105, "companyOfficers": [{"maxAge": 1, "name": "Mr. Mir A. Imran", "age": 67, "title": "Executive Chairman", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 40000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Talat  Imran", "age": 42, "title": "CEO & Director", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 105818, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Svai S. Sanford", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mir  Hashim", "age": 64, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alireza  Javadi", "title": "Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Groen J.D.", "age": 53, "title": "General Counsel", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bella  Vazquez", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kate  McKinley M.B.A.", "age": 47, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Arvinder  Dhalla", "title": "Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.12, "open": 1.09, "dayLow": 1.0284, "dayHigh": 1.155, "regularMarketPreviousClose": 1.12, "regularMarketOpen": 1.09, "regularMarketDayLow": 1.0284, "regularMarketDayHigh": 1.155, "payoutRatio": 0.0, "beta": 0.24, "forwardPE": -1.1089109, "volume": 579200, "regularMarketVolume": 579200, "averageVolume": 827161, "averageVolume10days": 163860, "averageDailyVolume10Day": 163860, "bid": 1.09, "ask": 1.17, "bidSize": 1, "askSize": 1, "marketCap": 65860256, "fiftyTwoWeekLow": 1.02, "fiftyTwoWeekHigh": 7.88, "priceToSalesTrailing12Months": 64.0664, "fiftyDayAverage": 1.4051, "twoHundredDayAverage": 2.02808, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 41102008, "profitMargins": 0.0, "floatShares": 23487373, "sharesOutstanding": 33570300, "sharesShort": 2398007, "sharesShortPriorMonth": 2465452, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0716, "heldPercentInsiders": 0.27102, "heldPercentInstitutions": 0.110190004, "shortRatio": 14.57, "shortPercentOfFloat": 0.1178, "impliedSharesOutstanding": 58803800, "bookValue": 0.06, "priceToBook": 18.666668, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -30018000, "trailingEps": -1.05, "forwardEps": -1.01, "enterpriseToRevenue": 39.982, "enterpriseToEbitda": -0.846, "52WeekChange": -0.8328358, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 1.12, "targetHighPrice": 14.0, "targetLowPrice": 5.0, "targetMeanPrice": 9.5, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 6, "totalCash": 27639000, "totalCashPerShare": 0.825, "ebitda": -48572000, "totalDebt": 29709000, "quickRatio": 1.411, "currentRatio": 1.495, "totalRevenue": 1028000, "debtToEquity": 850.53, "revenuePerShare": 0.036, "returnOnAssets": -0.65573996, "returnOnEquity": -3.91098, "grossProfits": 1028000, "freeCashflow": -15861625, "operatingCashflow": -35496000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -10.93774, "financialCurrency": "USD", "symbol": "RANI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 0.0, "regularMarketPrice": 1.12, "corporateActions": [], "postMarketTime": 1745611514, "regularMarketTime": 1745611200, "exchange": "NGM", "messageBoardId": "finmb_242425883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "earningsTimestamp": 1743451500, "earningsTimestampStart": 1743451500, "earningsTimestampEnd": 1743451500, "earningsCallTimestampStart": 1743453000, "earningsCallTimestampEnd": 1743453000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.05, "epsForward": -1.01, "epsCurrentYear": -0.85, "priceEpsCurrentYear": -1.317647, "fiftyDayAverageChange": -0.28509998, "fiftyDayAverageChangePercent": -0.2029037, "twoHundredDayAverageChange": -0.90808, "twoHundredDayAverageChangePercent": -0.44775355, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "postMarketChangePercent": -0.444444, "postMarketPrice": 1.12, "postMarketChange": -0.005, "regularMarketChange": 0.0, "regularMarketDayRange": "1.0284 - 1.155", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 827161, "fiftyTwoWeekLowChange": 0.100000024, "fiftyTwoWeekLowChangePercent": 0.09803924, "fiftyTwoWeekRange": "1.02 - 7.88", "fiftyTwoWeekHighChange": -6.76, "fiftyTwoWeekHighChangePercent": -0.857868, "fiftyTwoWeekChangePercent": -83.28358, "shortName": "Rani Therapeutics Holdings, Inc", "longName": "Rani Therapeutics Holdings, Inc.", "displayName": "Rani Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]